| UniProt ID | TM38B_HUMAN | |
|---|---|---|
| UniProt AC | Q9NVV0 | |
| Protein Name | Trimeric intracellular cation channel type B | |
| Gene Name | TMEM38B | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 291 | |
| Subcellular Localization |
Endoplasmic reticulum membrane Multi-pass membrane protein . |
|
| Protein Description | Monovalent cation channel required for maintenance of rapid intracellular calcium release. May act as a potassium counter-ion channel that functions in synchronization with calcium release from intracellular stores.. | |
| Protein Sequence | MDSPWDELALAFSRTSMFPFFDIAHYLVSVMAVKRQPGAAALAWKNPISSWFTAMLHCFGGGILSCLLLAEPPLKFLANHTNILLASSIWYITFFCPHDLVSQGYSYLPVQLLASGMKEVTRTWKIVGGVTHANSYYKNGWIVMIAIGWARGAGGTIITNFERLVKGDWKPEGDEWLKMSYPAKVTLLGSVIFTFQHTQHLAISKHNLMFLYTIFIVATKITMMTTQTSTMTFAPFEDTLSWMLFGWQQPFSSCEKKSEAKSPSNGVGSLASKPVDVASDNVKKKHTKKNE | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 121 | Phosphorylation | ASGMKEVTRTWKIVG HCCCCHHHEEEEEEC | 24.39 | 29116813 | |
| 123 | Phosphorylation | GMKEVTRTWKIVGGV CCCHHHEEEEEECCE | 23.03 | 29116813 | |
| 135 | Phosphorylation | GGVTHANSYYKNGWI CCEECCCEECCCCEE | 30.53 | 29116813 | |
| 136 | Phosphorylation | GVTHANSYYKNGWIV CEECCCEECCCCEEE | 20.47 | 29116813 | |
| 166 | Ubiquitination | TNFERLVKGDWKPEG ECHHHHHCCCCCCCC | 56.60 | 21890473 | |
| 170 | Ubiquitination | RLVKGDWKPEGDEWL HHHCCCCCCCCCCCC | 37.62 | - | |
| 186 | Phosphorylation | MSYPAKVTLLGSVIF CCCCEEEEEEEEEEE | 18.63 | - | |
| 190 | Phosphorylation | AKVTLLGSVIFTFQH EEEEEEEEEEEEEEC | 16.41 | - | |
| 232 | Phosphorylation | TTQTSTMTFAPFEDT CCCCCEEEEECHHHH | 19.41 | 28985074 | |
| 239 | Phosphorylation | TFAPFEDTLSWMLFG EEECHHHHHHHHHHC | 18.59 | 28985074 | |
| 258 | Phosphorylation | FSSCEKKSEAKSPSN CCCCCCHHCCCCCCC | 54.58 | 21712546 | |
| 262 | Phosphorylation | EKKSEAKSPSNGVGS CCHHCCCCCCCCCHH | 40.38 | 30266825 | |
| 264 | Phosphorylation | KSEAKSPSNGVGSLA HHCCCCCCCCCHHHC | 53.99 | 30266825 | |
| 269 | Phosphorylation | SPSNGVGSLASKPVD CCCCCCHHHCCCCCC | 20.53 | 30266825 | |
| 272 | Phosphorylation | NGVGSLASKPVDVAS CCCHHHCCCCCCCCC | 42.67 | 30266825 | |
| 273 | Ubiquitination | GVGSLASKPVDVASD CCHHHCCCCCCCCCC | 43.37 | 2190698 | |
| 279 | Phosphorylation | SKPVDVASDNVKKKH CCCCCCCCCCCCCCC | 29.57 | 25159151 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TM38B_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TM38B_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TM38B_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of TM38B_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 615066 | Osteogenesis imperfecta 14 (OI14) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-262, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-262 AND SER-264, ANDMASS SPECTROMETRY. | |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-279, AND MASSSPECTROMETRY. | |